Share Facebook Twitter LinkedIn Pinterest Email AbCellera Biologics prices oversubscribed $200M offering at $9.75/share
Trump signs memo enlisting private sector in cyber operations against foreign crime groups (XLK:NYSEARCA)August 13, 2026
Leslie’s withdraws FY2026 guidance while targeting capex well below $20M (NASDAQ:LESL)August 13, 2026
Atea outlines peak annual U.S. net revenue potential in excess of $700M with focus on mid-2028 HCV launch (NASDAQ:AVIR)August 13, 2026
